Ghost Tree Capital’s Standard BioTools LAB Stock Holding History

Ghost Tree Capital’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-150,000	Closed	-$1.35M	–	92
2016 Q2	$1.35M	Buy	+150,000	New	+$1.41M	0.39%	49
2016 Q1	–	Sell	-150,000	Closed	-$1.62M	–	60
2015 Q4	$1.62M	Buy	+150,000	New	+$1.47M	0.66%	39

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ghost Tree Capital's LAB Position: Q3 2016 in Review

Ghost Tree Capital sold out of Standard BioTools (LAB) in Q3 2016, closing a stake of 150,000 shares — an estimated $1.35M sold.

Ghost Tree Capital first reported a position in LAB in Q4 2015 and held it in 2 quarters. The position peaked at $1.62M in Q4 2015. 98 funds tracked by Wall St. Rank hold LAB as of Q3 2016.

Ghost Tree Capital reported no remaining Standard BioTools position as of Q3 2016 after selling out during the quarter.
Ghost Tree Capital sold 150,000 Standard BioTools shares in Q3 2016, an estimated $1.35M.
Ghost Tree Capital first reported a position in Standard BioTools in Q4 2015 and held it in 2 quarters.
Ghost Tree Capital's Standard BioTools position peaked at $1.62M in Q4 2015.
98 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2016.

Based on Ghost Tree Capital's 13F filing for Q3 2016, filed 14 Nov 2016.